舒泰神股价涨5.14%，银华基金旗下1只基金重仓，持有43.03万股浮盈赚取67.99万元

Group 1 - The core point of the news is that Shuyou Shen (Beijing) Biopharmaceutical Co., Ltd. experienced a stock price increase of 5.14%, reaching 32.30 CNY per share, with a trading volume of 505 million CNY and a turnover rate of 3.52%, resulting in a total market capitalization of 15.432 billion CNY [1] - The company was established on August 16, 2002, and went public on April 15, 2011. Its main business involves the research, production, and sales of biological products and some chemical drugs [1] - The revenue composition of the company includes 59.17% from injectable mouse nerve growth factor (Sutai Shen), 33.19% from compound polyethylene glycol electrolyte powder, and 7.63% from other products [1] Group 2 - From the perspective of major fund holdings, one fund under Yinhua Fund has a significant position in Shuyou Shen. The Yinhua Growth Smart Selection Mixed A Fund (024455) held 430,300 shares in the third quarter, accounting for 3.48% of the fund's net value, making it the ninth largest holding [2] - The estimated floating profit from this position today is approximately 679,900 CNY [2] - The Yinhua Growth Smart Selection Mixed A Fund (024455) was established on June 20, 2025, with a current size of 253 million CNY and a cumulative return of 5.31% since inception [3]